Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 10,000 shares at $18.74 ($188K) on 2008-02-15, disclosed to the SEC on 2008-02-15.
Scheduled sale ($188k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.67 | 2,000 | $37K | 19.8% |
| 2 | $18.68 | 600 | $11K | 5.9% |
| 3 | $18.69 | 100 | $2K | 1.0% |
| 4 | $18.71 | 100 | $2K | 1.0% |
| 5 | $18.73 | 1,790 | $34K | 17.8% |
| 6 | $18.74 | 100 |
| $2K |
| 1.0% |
| 7 | $18.75 | 100 | $2K | 1.0% |
| 8 | $18.76 | 310 | $6K | 3.1% |
| 9 | $18.77 | 600 | $11K | 6.0% |
| 10 | $19.00 | 2,244 | $43K | 22.6% |
| 11 | $19.01 | 1,100 | $21K | 11.1% |
| 12 | $19.03 | 339 | $6K | 3.4% |
| 13 | $19.04 | 17 | $324 | 0.2% |
| 14 | $19.05 | 500 | $10K | 5.1% |
| 15 | $19.06 | 100 | $2K | 1.0% |
| Total | $18.84 avg | 10,000 | $188K | 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |